Waldencast PLC (NASDAQ:WALD) Receives Consensus Rating of “Moderate Buy” from Analysts

Waldencast PLC (NASDAQ:WALD) has earned an average rating of “Moderate Buy” from the six research firms that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have given a buy recommendation to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $4.4167.

Several brokerages have commented on WALD. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Waldencast in a research report on Wednesday, January 21st. Canaccord Genuity Group lowered their price objective on shares of Waldencast from $5.00 to $4.00 and set a “buy” rating on the stock in a research note on Tuesday, November 25th. Telsey Advisory Group lowered shares of Waldencast from an “outperform” rating to a “market perform” rating and set a $3.00 target price on the stock. in a research report on Tuesday, November 25th. Finally, Jefferies Financial Group started coverage on shares of Waldencast in a report on Wednesday, January 14th. They issued a “buy” rating and a $2.00 price target for the company.

Waldencast Trading Down 5.7%

Waldencast stock opened at $1.58 on Thursday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.53 and a quick ratio of 0.67. Waldencast has a fifty-two week low of $1.45 and a fifty-two week high of $3.72. The firm has a fifty day moving average price of $1.98 and a two-hundred day moving average price of $1.93.

Waldencast (NASDAQ:WALD) last issued its quarterly earnings results on Monday, November 24th. The company reported ($0.69) earnings per share (EPS) for the quarter. The firm had revenue of $66.14 million during the quarter. On average, research analysts anticipate that Waldencast will post -0.14 EPS for the current year.

Institutional Investors Weigh In On Waldencast

A number of institutional investors have recently added to or reduced their stakes in the company. UBS Group AG increased its stake in Waldencast by 466.2% during the third quarter. UBS Group AG now owns 838,536 shares of the company’s stock valued at $1,660,000 after acquiring an additional 690,441 shares during the period. Milestones Administradora de Recursos Ltda. grew its holdings in shares of Waldencast by 10.3% during the 3rd quarter. Milestones Administradora de Recursos Ltda. now owns 2,425,677 shares of the company’s stock worth $4,803,000 after purchasing an additional 225,677 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Waldencast by 62.2% during the second quarter. Geode Capital Management LLC now owns 586,566 shares of the company’s stock valued at $1,437,000 after purchasing an additional 224,905 shares during the period. McAdam LLC raised its stake in shares of Waldencast by 174.6% in the third quarter. McAdam LLC now owns 63,014 shares of the company’s stock valued at $125,000 after purchasing an additional 40,063 shares in the last quarter. Finally, Squarepoint Ops LLC bought a new position in Waldencast in the third quarter worth $78,000. 41.97% of the stock is owned by institutional investors and hedge funds.

Waldencast Company Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. The company also offers clean makeup products under the Milk Makeup brand. It sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners.